MetaCap

Alphatec Holdings Inc. (ATEC)

NASDAQ: ATECHealth CareMedical/Dental InstrumentsUSD

10.25-0.29 (-2.75%)

At close: Oct 7, 4:00 PM ET · Delayed 15 min

ATEC stock chart

Technical analysis

Key statistics

All statistics
EPS (TTM)
-$0.70
52-week range
6.82 – 23.29
Day range
10.18 – 10.66
Volume / Avg
2.44M / 2.16M
Beta
—
Next earnings
Oct 29, 2026

52-week range

$6.82$23.29

ATEC stock today

On Oct 7, ATEC ended the session at $10.25, shedding $0.29 (2.75%), versus the S&P 500's 0.22% decline. Shares are 56.0% below their 52-week high of $23.29, set on Jan 8, 2026 and 50.3% above the 52-week low of $6.82, in the middle of the past year's range. ATEC is down 51.3% year to date, underperforming the S&P 500 (+14.0%). Over the past 12 months, the stock has lost 23.8%.

Alphatec has posted a net loss over the last twelve months (EPS of -$0.70), so its P/E ratio is not meaningful. Alphatec's next earnings report is expected on Oct 29, 2026.

Summary generated from market data by MetaCap's automated system. Methodology

About Alphatec

Company profile

Alphatec Holdings, Inc., a medical technology company, designs, develops, and advances technologies for the surgical treatment of spinal disorders in the United States and internationally. The company manufactures and sells implants, instruments, imaging equipment, and spare parts. It offers Alpha InformatiX product platform, including EOS imaging system that provides full-body imaging; SafeOp Neural InformatiX System that automates electromyographic, somatosensory evoked potential, and motor evoked potential monitoring; and Valence, an intra-operative system that integrates navigation and robotics into spine procedures, as well as Sigma Prone TransPsoas (PTP) Access and PTP Patient Positioning Systems.

Industry
Medical/Dental Instruments
CEO
Mr. Patrick S. Miles
Headquarters
Carlsbad, CA
Employees
913
IPO year
2006

Analyst forecast

Forecast

Consensus (14 analysts)

none

Avg. price target

$15.79+54.05%

  • Strong buy 3
  • Buy 11
  • Hold 0
  • Sell 0
  • Strong sell 0

Target range

Low $12.00High $24.00

Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.

Earnings

Earnings history
Next report
Oct 29, 2026
EPS estimate
$-0.07

Alphatec peers

Health Care sector
ATEC peer companies
CompanyPrice% ChgMarket capCompare
KMTSKestra Medical Technologies Ltd.26.49-2.25%$1.58Bvs ATEC
XRAYDENTSPLY SIRONA Inc.8.54+0.23%$1.70Bvs ATEC
NVCRNovoCure Limited14.66-2.07%$1.71Bvs ATEC
LMATLeMaitre Vascular Inc.79.31+0.33%$1.81Bvs ATEC
INSPInspire Medical Systems Inc.67.45-1.10%$1.95Bvs ATEC
UFPTUFP Technologies Inc.292.87-3.30%$2.27Bvs ATEC
SIShoulder Innovations Inc.18.71-2.25%$389.52Mvs ATEC
LUCDLucid Diagnostics Inc.0.6235+3.92%$119.06Mvs ATEC

Indexes, lists and sector

Alphatec stock FAQ

What is Alphatec's stock price today?

ATEC last traded at $10.25 as of Oct 7, 4:00 PM EDT, down 2.75% on the day. Prices are delayed at least 15 minutes.

Does Alphatec pay a dividend?

No. Alphatec does not currently pay a regular cash dividend.

When is Alphatec's next earnings date?

Alphatec is expected to report earnings on Thursday, October 29, 2026. Analysts expect EPS of $-0.07.

Who is Alphatec's CEO?

Mr. Patrick S. Miles is the chief executive officer of Alphatec Holdings Inc., which has about 913 employees.

Has ATEC ever split its stock?

Yes. The most recent ATEC stock split was a 1-for-12 split on Aug 25, 2016.

What is the ATEC 52-week high?

The 52-week high for ATEC is $23.29 and the 52-week low is $6.82. The stock is currently 56.0% below its high.

Compare ATEC